秦悦于英国伦敦大学国王学院（King’s College London）获得药物科学专业博士学位，于2025年加入GMU iCAN Lab，担任博士后研究员。她专门从事医学应用的生物材料脂质纳米颗粒（LNPs）递送核酸如mRNA，pDNA，siRNA等的研究，主要专注于LNP调控免疫系统治疗疾病的研究。目前项目集中在建立可调控免疫微环境的LNP递送核酸用于心血管疾病和肿瘤免疫的研究。她的研究旨在为心血管疾病和肿瘤免疫治疗提供创新解决方案。
Yue Qin obtained her Ph.D. degree in Pharmaceutical Sciences from King’s College London, UK. In 2025, she joined the GMU iCAN Lab as a postdoctoral researcher. She focuses on the development of lipid nanoparticles (LNPs) for nucleic acid (such as mRNA, pDNA, siRNA, etc.) delivery to modulate immune system for diseases therapy applications. Her current projects work on developing LNPs that can modulate the immune microenvironment for the delivery of nucleic acids in cardiovascular disease and cancer immunotherapy. Her research aims to provide innovative solutions for cardiovascular disease and cancer immunotherapy.